trusted by 100+ Patients

RGCC Onconomics Panels

Personalised Cancer Treatment Optimisation

Treatment Intro

What are RGCC Onconomics Panels?

RGCC's Onconomics panels are cutting-edge diagnostic tools designed to personalise cancer treatment by assessing the effectiveness of various therapies and natural substances on an individual's cancer profile. 

These tests provide comprehensive insights into circulating tumor cell (CTC) counts, genetic expressions, and the responsiveness of cancer cells to different treatments, allowing for the development of highly effective, tailored treatment plans.

Why to Choose it

Why Choose RGCC Onconomics Panels?

RGCC Onconomics Panels analyse how your circulating tumour cells respond to a wide range of chemotherapy agents, targeted therapies, and natural substances - helping to personalise your treatment plan and improve its effectiveness.
🌿

Personalised Cancer Treatment 

Tailors therapy plans to an individual’s unique cancer profile, maximising the effectiveness of treatment.
🦠

Comprehensive Analysis

Provides a complete picture by evaluating genetic, physiological, and therapeutic data to predict how cancer cells will respond to various therapies.
🛡️

Chemotherapy Sensitivity Testing

Assesses the effectiveness of more than 90 chemotherapy agents on cancer cells to choose the best therapeutic approach.
🧠

Natural Substance Efficacy

Evaluates the impact of over 50 natural substances and plant extracts against cancer cells, offering alternative or complementary treatment options.
⚖️

CTC Monitoring

Tracks the presence and number of circulating tumor cells, an essential indicator of cancer progression and treatment efficacy

onconomics plus

Onconomics Plus: Comprehensive Treatment Assessment

Onconomics Plus provides a thorough and extensive analysis to guide personalised cancer treatment.

This advanced panel includes:

CTC Count: Quantifies the number of circulating tumor cells in the bloodstream to monitor disease progression.

Genetic Expression and Profiling: Analyzes genetic markers and physiological traits of cancer cells to determine how they may react to different treatments.

Chemotherapy Sensitivity: Examines how well over 90 different chemotherapy and targeted therapies work against the patient’s specific cancer cells.

Natural Therapy Evaluation: Tests the effectiveness of over 50 natural substances to provide additional therapeutic options that may complement or enhance traditional cancer treatments.

onconomics Extracts+

Onconomics Extracts+: Natural Treatment Efficacy Profiling

The Onconomics Extracts+ test extends the capabilities of the Onconomics Extracts test by focusing on the effectiveness of natural substances and plant extracts.

This panel offers:

CTC Count: Measures the number of circulating tumor cells, a critical marker for cancer progression and treatment response.

Genetic Expression Analysis: Provides deeper insights into the genetic profile of cancer cells to help predict responses to natural therapies.

Natural Substances Effectiveness: Evaluates how over 50 natural substances impact the cancer cells, offering additional treatment pathways.

Resistance Profiling: Identifies resistance factors to various treatments, both conventional and natural, to inform the best course of action.

onconomics Extracts

Onconomics Extracts: Targeted Natural Therapy Assessment

Onconomics Extracts focuses solely on the evaluation of natural substances and plant extracts for cancer treatment.

This test includes:

CTC Count: Assesses the level of circulating tumor cells to provide real-time data on cancer progression.

Natural Substances Efficacy: Identifies the effectiveness of over 50 natural substances against the patient’s cancer cells, offering a tailored approach to natural therapy.

The Process

How We Use Onconomics Plus in Our Therapy

At Vervé, we believe that every patient’s journey toward recovery should be as unique as their individual biology. To achieve this, we’ve partnered with RGCC to utilize their advanced Onconomics Plus test - a cutting-edge diagnostic tool that provides detailed insights into your tumor’s behavior. This comprehensive test evaluates over 50 chemotherapeutic agents and more than 50 natural substances, delivering critical data on the sensitivity and resistance of your cancer cells.
Book a consultation
Phase 1
Data-Driven Personalization for Maximum Efficacy
01
Targeted Identification of Effective Agents
We determine which chemotherapy drugs demonstrate the highest cytotoxic activity against your individual cancer cells, allowing us to select those most likely to deliver therapeutic benefit while minimising unnecessary side effects.
02
Evaluation of Natural Substances
The test also evaluates the efficacy of clinically validated natural compounds—including curcumin, high-dose vitamin C, and plant-derived substances—so that any complementary therapies we incorporate are both scientifically supported and safe.
03
Curated, Holistic Treatment Plans
Our team integrates the insights from Onconomics Plus with your full clinical profile to design a personalised treatment strategy that combines targeted conventional therapies with effective natural agents, supporting both cancer control and your overall well-being.
Phase 2
Commitment to Safety, Evidence, and Expertise
04
Scientific Rigour and Evidence-Based Decisions
Every treatment component we recommend is guided by robust data from the Onconomics Plus test, ensuring a highly individualised approach based on the unique molecular characteristics of your cancer.
05
Ongoing Monitoring and Adaptive Treatment
Through periodic liquid biopsies and continuous monitoring, we track your cancer’s response and evolution over time, enabling us to adapt your treatment plan as needed to maintain maximum therapeutic impact.
06
Expert Interpretation by Accredited Practitioners
All Onconomics Plus test results are interpreted by Vervé practitioners who are accredited by RGCC, ensuring that each clinical decision is informed by expert knowledge of personalised oncology and the latest scientific advancements.

FAQs

01

What does the Onconomics Plus test analyze?

The test evaluates how your cancer cells respond to a wide panel of conventional chemotherapy drugs and over 50 natural substances. It provides insights into genetic and physiological expressions that influence how your cancer behaves and responds to treatment.

02

How is my treatment personalized using this test?

By identifying the most suitable treatments for your unique cancer cell profile, we develop a targeted approach that includes both conventional therapies and validated natural compounds. This ensures each component of your treatment journey is based on scientific evidence and tailored for effectiveness.

03

Does this test replace a tissue biopsy?

No. While the Onconomics Plus test offers highly advanced, real-time insights via a blood sample, it complements rather than replaces a tissue biopsy. It provides dynamic data on circulating tumor cells, which is particularly useful for ongoing monitoring of cancer status.

04

How do I know that the natural substances recommended are safe?

The natural substances included in the Onconomics Plus analysis have undergone rigorous scientific testing. This evidence-based approach ensures that we only incorporate therapies that are both safe and effective.

05

How are chemotherapy agents and natural substances assessed?

The test evaluates the cancer targeting properties of over 90 chemotherapy agents and 50+ natural substances. This helps determine which agents your specific cancer cells are most sensitive to, offering a data-backed foundation for designing treatment protocols.

06

Are the natural substances always included in the treatment plan?

Not all substances tested will be included in your treatment. Only those shown to be effective against your cancer cells—and considered safe—are recommended by our medical team.

07

Can this test be used for nervous system cancers?

Onconomics testing may be limited in cases of central nervous system primary or nervous system primary tumors, as these cancers may not shed circulating tumor cells into the bloodstream in measurable amounts. Your medical team will advise whether the test is appropriate based on your diagnosis.

08

Will my treatment plan change over time?

Yes, we use periodic liquid biopsies to monitor your response and detect any changes in resistance or sensitivity, ensuring your treatment protocols stay optimised throughout your recovery.